IGI (IG)
Add to Watchlists Create an AlertIG Key Stats
| Income Statement | |
| Revenue TTM | 10.41M |
| Revenue Quarterly YoY Growth | 101.0% |
| EPS Diluted TTM | -0.0891 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -3.449M |
| Profitability | |
| Gross Profit Margin Quarterly | 30.08% |
| Profit Margin Quarterly | -6.98% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 69.01M |
| Enterprise Value | 72.38M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 15.67 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.3115 |
| Free Cash Flow | -1.191M |
| Return on Equity | -78.79% |
IG News
- IGI LABORATORIES, INC Files SEC form 10-Q, Quarterly Report May 15
- IGI Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha Apr 25
- IGI Laboratories Inc Earnings Call scheduled for 4:30 pm ET today Apr 25
- IGI Laboratories Announces 1st Quarter 2013 Results Business Wire Apr 25
- IGI LABORATORIES, INC Files SEC form 8-K, Results of Operations and Financial Co... Apr 25
- Q1 2013 IGI Laboratories Inc Earnings Release - Time Not Supplied Apr 25
- IGI Laboratories to Hold Conference Call for 1st Quarter 2013 Results Business Wire Apr 11
- IGI Laboratories to Present at 12th Annual Needham & Company Annual Healthcare C... Apr 5
- IGI Laboratories announces 10th ANDA submission Apr 4
- IGI Laboratories, Inc. Announces Tenth ANDA Submission Business Wire Apr 4
IG Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). IGI is up 53.85% over the last year vs S&P 500 Total Return up 27.77%, Acasti Pharma up 11.79%, and Durata Therapeutics up 0.00%.
IG Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these IG related companies
Pro Ratings for IG
Pro Report PDF for IG
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download IG Pro Report PDF
Pro Strategies Featuring IG
Did IGI make it into our Pro Portfolio Strategies?
IG Profile
Sector: Healthcare
Industry: Biotechnology
Other IG Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IG | 1.60 | +0.03 | +1.91% | 69.01M |
